The revised guidelines also will lead to more than $20 million in extra health care costs, the research shows.

HBV infection at birth or during early infancy can lead to lifelong health problems such as chronic liver disease and liver ...

Lytical’s iStatis test delivers results in 15 minutes in clinical and community settings iStatis Hepatitis B Surface Antigen ...

The decision by the Center for Disease Control and Prevention to stop recommending giving infants a dose of the hepatitis B ...

Countries are making measurable progress in combatting viral hepatitis, but the disease remains a major global health ...

FDA regulatory momentum includes priority review and breakthrough therapy designation for a potential first-in-class CHB ...

The FDA has accepted for Priority Review the New Drug Application for bepirovirsen for the treatment of adults with chronic hepatitis B.

Hepatitis B is a viral infection that impacts the liver. To test for hepatitis B, a doctor can perform a blood test that detects hepatitis B surface antigens. A positive result indicates a hepatitis B ...

The Trump administration’s recommendation against universal hepatitis B vaccination for babies on the day they’re born could ...

Researchers found that the decision to delay the once-universal hepatitis B shot for babies will likely cause a surge in ...

The World Health Organization (WHO) released a new report on hepatitis today, marking the World Hepatitis Summit. Since 2015, ...